Article Details
Retrieved on: 2024-01-30 21:59:42
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Bebtelovimab is authorized to be administered for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and ...
Article found on: covid19.lilly.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here